US EditionDaily aspirin after a heart attack can reduce the risk of future events, study finds
- Taking aspirin daily may decrease the risk of type 2 diabetes in people over 65, according to a study. Over a four-year period, researchers observed a 15% reduction in the condition and a slower increase in fasting plasma glucose levels among over 8,000 participants. However, these findings do not alter current guidelines on aspirin use for older adults.
- Previous research indicated that 100mg of daily aspirin did not have benefits for older individuals and posed a higher risk of hemorrhage. The new study was a follow-up to the previous research and found more promising results. The lead researcher, Professor Zoungas, emphasizes the importance of taking daily aspirin only when there is a medical reason, such as after a heart attack.
- While the possible link between aspirin and diabetes is still unclear, Diabetes UK advises against daily low-dose aspirin due to the risk of serious bleeding. Maintaining a healthy weight, having a balanced diet, and being physically active are recommended for reducing the risk of diabetes.
12 Articles
12 Articles
An aspirinette a day helps fight diabetes. This is the result of a study that comes from Australia, where some researchers are evaluating...
Eliminating five risk triggers can halve the risk of contracting strokes and heart attacks: here are the results of an American study
Low-dose aspirin linked to 15% lower risk of type 2 diabetes in older adults
New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) shows that use of low dose (100mg daily) aspirin among older adults aged 65 years and older is associated with a 15% lower risk of developing type 2 diabetes.
Daily aspirin after a heart attack can reduce the risk of future events, study finds
For people who have previously had a heart attack, taking a daily aspirin could reduce their risk of a repeat cardiac event or stroke, according to a recent Danish study. The findings were presented at the ESC Congress 2023 in Amsterdam this week. "Our findings support current clinical guidelines on aspirin therapy following myocardial infarction (heart attack)," said study author Dr. Anna Meta Kristensen of Bispebjerg and Frederiksberg Hospital…
Coverage Details
Bias Distribution
- 46% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
